Novo Nordisk - ADR

NYSE:NVO   3:59:40 PM EDT
+0.14 (+0.19%)
4:00:00 PM EDT: $72.37 +0.04 (+0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)128.39B
Current PE3.05
Forward PE 23.26
2yr Forward PE 20.9
See more stats
Estimates Current Quarter
Revenue$5.31 Billion
Adjusted EPS$0.81
See more estimates
10-Day MA$72.93
50-Day MA$71.58
200-Day MA$68.04
See more pivots

Novo Nordisk A/S Stock, NYSE:NVO

Novo All, Novo All, Bagsvrd, Capital Region 2880
Phone: +
Number of Employees: 45323


Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsvrd, Denmark.